World Antibiotic Markets to 2022

World Antibiotic Market is estimated to grow at a substantial CAGR in the forecast period as the scope, product types, and its applications are increasing across the globe. “Antibiotics”, also known as “Antimicrobials” and “Antibacterials”, constitute a group of medicines used for checking contaminations caused by bacteria and certain parasites by hindering the development of microorganisms or killing them.

The factors that propel the growth of the Antibiotic Market include growing investments in R&D by various biotech companies, rising cases of bacterial infections such as coughing, fever, inflammation, and diarrhea, favorable government initiatives. On the other hand, there are factors that may hamper the growth of the market including high cost of drugs. 

Antibiotic Market may be explored by drug class, applications, and geography. Antibiotic Market may be explored by drug class as Penicillin’s, Fluoroquinolones, Macrolides, Aminoglycosides, Carbapenems, Sulfonamides, Cephalosporins, and others. Antibiotic Market could be explored based on mechanism as Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, and RNA Synthesis Inhibitors. 

Antibiotic Market is categorized based on geography into North America, Latin America, Japan, Middle East and Africa, Western Europe, Asia Pacific, and Eastern Europe. Asia-Pacific accounted for the major share of the Antibiotic Market Size in 2017 and will continue to lead in the forecast period. The growth of this region is mainly attributed to occurrence of favorable regulatory reforms, several infectious diseases, and substantial demand for generic drugs.

The key players contributing in the robust growth of the Antibiotic Market comprise Astellas Pharma, Inc, Pfizer Inc., Roche, Bristol-Myers Squibb Co., Novartis AG, Bayer HealthCare AG, Abbott Laboratories, Takeda Pharmaceutical Company, Ltd., Middlebrook Pharmaceuticals, GlaxoSmithKline Plc, Daiichi Sankyo Company, Ltd., Kyorin Pharmaceutical Co., Ltd., and Eli Lilly and Co. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

The report package World Antibiotic Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for antibiotics in the world. Along with a global antibiotics market report, the package includes country reports from the following countries:

Armenia, Australia, Austria, Bangladesh, Belgium, Bolivia, Bosnia Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Latvia, Lebanon, Lithuania, Macedonia, Malawi, Malaysia, Mexico, Moldova, Morocco, Nepal, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Tanzania, Thailand, Trinidad and Tobago, Turkey, Ukraine, United Kingdom, United States, Uruguay, Vietnam

The research includes historical data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

The reports help answer the following questions:

- What is the size of the antibiotic market in the world and in different countries?
- How is the market split into different types of antibiotics?
- How are the overall market and different product types growing?
- How is the market predicted to develop in the future?

The latest industry data included in the reports:

- Demand for antibiotics, 2011-2022
- Antibiotic market size by product type, 2011-2022
- Growth rates of the overall market and different product segments, 2011-2022
- Shares of different product segments of the overall market, 2011, 2017, and 2022

The market data is given for the following product segments: 

Chloramphenicol
Erythromycin
Penicillins
Streptomycins
Tetracyclines
Other antibiotics
Medicaments containing penicillins
Medicaments containing other antibiotics

Among the key reasons to purchase include the following:

- Gain an outlook of the historical development, current market situation, and future outlook of the antibiotic market in the world to 2022
- Track industry developments and identify market opportunities
- Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects
- Save time and money with the readily accessible key market data included in the reports. The data is clearly presented and can be easily incorporated into presentations and internal reports.